BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) released its earnings results on Thursday. The company reported $0.22 EPS for the quarter, topping analysts' consensus estimates of $0.19 by $0.03, Zacks reports. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The company had revenue of $3.05 billion for the quarter, compared to analysts' expectations of $3.02 billion.
BrightSpring Health Services Trading Down 8.3 %
NASDAQ BTSG traded down $1.45 on Monday, hitting $16.03. 2,558,748 shares of the stock were exchanged, compared to its average volume of 1,606,768. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35. The stock has a fifty day moving average price of $20.04 and a two-hundred day moving average price of $17.56. The firm has a market capitalization of $2.79 billion, a P/E ratio of -61.65 and a beta of 2.20. BrightSpring Health Services has a 52-week low of $7.85 and a 52-week high of $24.82.
Analysts Set New Price Targets
A number of equities research analysts have commented on BTSG shares. Morgan Stanley raised their target price on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 17th. Bank of America lifted their price objective on shares of BrightSpring Health Services from $19.00 to $21.00 and gave the company a "buy" rating in a research report on Wednesday, December 11th. Wells Fargo & Company lifted their price objective on shares of BrightSpring Health Services from $17.00 to $21.00 and gave the company an "overweight" rating in a research report on Wednesday, November 27th. UBS Group lifted their price objective on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a "buy" rating in a research report on Wednesday, January 29th. Finally, CJS Securities initiated coverage on shares of BrightSpring Health Services in a research report on Thursday, December 12th. They set an "outperform" rating and a $27.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $21.67.
Get Our Latest Report on BrightSpring Health Services
BrightSpring Health Services Company Profile
(
Get Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Further Reading
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
